NEO logo
NeoGenomics, Inc.(NEO)
Last print unknown agoAbout this dataData status
$16.42▼-0.23 (-1.38%)Stale · unknown oldEarnings · Oct 28

NEO Operating Cash Flow (Statement)

$22.05MTTM · USD

Period ending:

NEO FY Cash from OperationsUSD
NEO FY Cash from Operations2000-12-31: -$177.13K2001-12-31: -$77.41K2002-12-31: -$384.80K2003-12-31: -$532.37K2004-12-31: -$658.13K2005-12-31: -$902.05K2006-12-31: -$693.78K2007-12-31: -$2.64M2008-12-31: -$138.31K2009-12-31: -$1.50M2010-12-31: -$2.05M2011-12-31: $69.00K2012-12-31: -$492.00K2013-12-31: $2.23M2014-12-31: $9.45M2015-12-31: $6.39M2016-12-31: $21.48M2017-12-31: $18.04M2018-12-31: $44.79M2019-12-31: $23.37M2020-12-31: $1.46M2021-12-31: -$26.72M2022-12-31: -$65.99M2023-12-31: -$1.95M2024-12-31: $7.02M2025-12-31: $5.23M$44.79M-$65.99M
2000-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

NEO operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 26 observations from Dec 31, 2000 to Dec 31, 2025.

Neogenomics Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
5,230,000
7,023,000
-1,953,000
-65,993,000
-26,723,000
1,460,000
23,369,000
44,786,000
18,037,000
21,477,000
6,393,000
9,450,000
2,227,000
-492,000
69,000
-2,052,000
-1,500,417
-138,306
-2,642,591
-693,782
-902,051
-658,133
-532,366
-384,796
-77,407
-177,131

Compare operating cash flow (statement)

All NEO financial metrics · NEO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.